U.S. Chemicals Stock News

Why Arcos Dorados' Latest Earnings Matter for Investors Arcos Dorados Holdings (ARCO) reported first quarter 2026 revenue of US$1,215.96 million and net income of US$36.14 million, compared with US$1,076.59 million and US$13.93 million a year earlier. Basic earnings per share from continuing operations reached US$0.17, up from US$0.07 in the prior year period, giving investors fresh data on how the McDonald’s franchise operator uses its Latin American footprint to generate profit. See our...

Old Republic International (ORI) has just paired a fresh fixed income move with a cash payout to shareholders, completing a US$699.818 million senior unsecured notes offering and affirming a quarterly dividend of US$0.315 per share. See our latest analysis for Old Republic International. Despite the fresh US$699.818 million notes and the steady dividend signal, Old Republic International’s share price has eased in recent months, with a 30 day share price return decline of 2.57% and a year to...

Recent performance snapshot and business context Oculis Holding (NasdaqGM:OCS) has attracted fresh attention after recent trading, with the stock last closing at $29.49. Investors are weighing this price against the company’s clinical-stage pipeline and current financial profile. See our latest analysis for Oculis Holding. At $29.49, the stock has pulled back around 4.9% over the last day but still sits on a year-to-date share price return of about 47%, alongside a 1-year total shareholder...

Roblox (RBLX) has put a new US$3b share repurchase program on the table, even as it trims full year revenue guidance and faces legal questions about past user metrics and scrutiny related to platform safety. See our latest analysis for Roblox. The share repurchase announcement comes after a sharp reset in expectations, with the stock down 40.5% year to date on a share price basis and the 1 year total shareholder return declining 41.5%, while the 3 year total shareholder return remains...

Nano Nuclear Energy Inc. recently announced that, in 2026, the U.S. Nuclear Regulatory Commission accepted the Construction Permit Application for its KRONOS MMRTM microreactor at the University of Illinois Urbana-Champaign, allowing formal safety, environmental, and technical review to begin. This progress places KRONOS MMRTM among a small group of advanced Generation IV microreactors in the U.S. licensing pipeline, underlining Nano Nuclear’s push to accelerate commercialization through...

Earlier in May, C.H. Robinson Worldwide received a bullish analyst upgrade from Jefferies, which highlighted the company’s early-stage technology and productivity transformation and its strong balance sheet as it prepares for potential industry consolidation in freight brokerage. Management’s focus on Lean practices, AI-driven productivity gains, and readiness to act as a consolidator amid regulatory changes is reshaping how investors view C.H. Robinson’s role in a changing logistics...

Rocket Lab (RKLB) is back in focus after two contrasting announcements: a plan to raise up to US$3b via an at the market equity program, and a new US$90m U.S. Space Force satellite contract. See our latest analysis for Rocket Lab. The stock has been volatile around these headlines, with dilution concerns from the US$3b at the market program pulling against optimism from the new US$90m Space Force deal and recent successful missions. At the same time, the 30 day share price return of 70.38%...

Why Star Bulk Carriers (SBLK) is on investors’ radar Star Bulk Carriers (SBLK) has drawn attention after a strong period for the stock, with gains over the past month and past 3 months prompting fresh questions about how the shipping company is valued. See our latest analysis for Star Bulk Carriers. That recent momentum, including an 8.96% 1 month share price return and a 36.29% year to date share price return, sits alongside a 1 year total shareholder return of 67.60%. This indicates that...

Recent share performance and business snapshot CareDx (CDNA) has drawn investor attention after recent share price moves, with the stock last closing at $21.63 and recording mixed short term returns over the past week, month and past 3 months. The company focuses on transplant related diagnostics and software, with US$412.82 million in annual revenue and a reported net income loss of US$8.192 million, placing it among mid cap US healthcare stocks. See our latest analysis for CareDx. Recent...

Spotify Technology (NYSE:SPOT) is back in the spotlight after its 2026 Investor Day, where the company detailed generative AI tools for fan-made covers and remixes under fresh licensing agreements with Universal Music Group. See our latest analysis for Spotify Technology. The stock’s 1 day share price return of 6.11% and 7 day return of 16.82% suggest momentum has picked up again following Investor Day, even though the year to date share price return is down 9.59%. At the same time, the 3...

Aveanna Healthcare Holdings (AVAH) has put fresh earnings in focus after reporting first quarter results, with higher sales and net income than a year earlier and slightly raised full year revenue guidance. See our latest analysis for Aveanna Healthcare Holdings. At a share price of US$7.33, Aveanna has pulled back about 4% over the past week but is still up roughly 12% over 30 days. Its 1 year total shareholder return of about 38% and very large 3 year total shareholder return suggest...

In recent months, First Advantage reported Q1 2026 results showing 8.6% revenue growth, expanding margins, and a move from loss-making to positive earnings per share, followed by an analyst upgrade from Barclays citing stronger operational execution. An interesting aspect of this development is that these improvements arrived after a period of modest earnings expansion and declining free cash flow margins, suggesting a potential shift in how efficiently the company converts its market...

Event context and quick snapshot Texas Capital Bancshares (TCBI) has drawn investor attention after recent trading, with the stock last closing at US$99.39 and showing limited movement over the past month along with a stronger total return profile over the past 3 months and year. See our latest analysis for Texas Capital Bancshares. The recent 1-year total shareholder return of 39.12% and 3-year total shareholder return of 100.67% suggest momentum has been building. This contrasts with the...

In recent months, Citizens Financial Group reported mixed first-quarter results, with revenue roughly matching forecasts, slightly higher net interest income, but tangible book value per share coming in below analyst estimates amid a softer backdrop for regional banks. At the same time, its multiyear "Reimagine the Bank" program, targeting about US$450 million in run-rate efficiency gains, underscores management’s emphasis on reshaping operations and cost structure despite near-term...

Earlier in May 2026, Dynex Capital’s board declared a US$0.17 per-share cash dividend for May, payable on June 1, 2026, to shareholders of record as of May 21, 2026. At the same time, shareholders approved doubling the company’s authorized common shares to 720 million and backed board, compensation, and governance measures, signaling support for Dynex Capital’s evolving capital structure and leadership framework. We will now examine how the doubling of authorized common shares shapes Dynex...

Affirm Holdings (AFRM) is back in focus after announcing that its buy now, pay later options will roll out across Google Search, AI Mode, and the Gemini app via Google Pay checkout. See our latest analysis for Affirm Holdings. The news around Google integration comes as Affirm's share price shows mixed momentum, with a 36.24% 90 day share price return and a 32.29% 1 year total shareholder return, but a year to date share price decline of 11.90% from the latest close of US$65.22. If this kind...

Earlier in May 2026, FTI Consulting appointed Andreas P. Stöcklin to lead its Transactions practice across Continental Europe and named Emanuele Grasso as Senior Managing Director and head of the Corporate Finance segment in Italy, both joining the EMEA management structure to deepen M&A and transaction support capabilities. These hires bring decades of cross-border deal experience and board advisory expertise from firms such as Kroll and PwC, highlighting FTI Consulting’s intent to build...

In recent months, AngloGold Ashanti has faced increased scrutiny as ABSA Securities downgraded the miner, while insiders, including the CEO and a director, sold shares without any offsetting insider purchases. This combination of analyst caution on costs and operations alongside ongoing insider selling raises fresh questions about how management views the company’s current positioning. Now we’ll examine how ABSA’s downgrade, rooted in mining cost inflation and operational risk, may reshape...

Sun Communities (SUI) has drawn investor attention after recent share moves, with the stock up 1.2% over the past day and 5.1% over the past week, despite declines over the past month. See our latest analysis for Sun Communities. The recent 7 day share price return of 5.1% contrasts with more muted year to date gains of 4.6% and a 1 year total shareholder return of 10.2%. This suggests near term momentum is improving from a softer medium term trend. If this move in Sun Communities has you...

Illumina, Inc. has added former Labcorp Executive Chairman and CEO David P. King to its Board of Directors, following the May 21, 2026 annual shareholder meeting and alongside equity grants to several directors as part of their compensation. King’s deep background in large-scale diagnostics businesses and clinical operations underlines Illumina’s push to embed genomics more firmly into everyday medical decision-making as it refreshes its Board. We’ll now examine how King’s board appointment,...

Earlier in May 2026, BioMarin reported that its Phase 3 CANOPY-HCH-3 trial of VOXZOGO in children with hypochondroplasia met its primary endpoint, showing a statistically significant 2.33 cm/year gain in annualized growth velocity over placebo and meaningful improvements in arm span with a safety profile consistent with prior use in achondroplasia. Because hypochondroplasia currently has no approved therapies, these data and BioMarin’s plan to file a supplemental FDA application in the third...

How Balchem’s Recent Performance Frames the Story for Investors Balchem (BCPC) has been steady over the past day, but the stock is up about 1.4% over the past week and down roughly 7% over the past month, prompting closer investor attention. See our latest analysis for Balchem. That recent 7% one month share price pullback, alongside a 5.0% year to date share price gain and a 3 year total shareholder return of 34.3%, suggests momentum has cooled but long term holders have still been...

Recent share performance and context Oppenheimer Holdings (OPY) has seen mixed share performance recently, with the stock down about 3% over the past day and roughly 9% over the past month, yet up around 9% in the past 3 months. See our latest analysis for Oppenheimer Holdings. Despite the recent 9% decline in the 1 month share price return to US$93.86, momentum over the year still looks constructive. A 29.21% year to date share price return and a 50.07% 1 year total shareholder return...

In May 2026, MicroVision, Inc. reported first quarter 2026 results, with sales rising to US$935,000 from US$589,000 a year earlier, while net loss narrowed to US$25.29 million and basic loss per share improved to US$0.08 from US$0.12. This combination of higher sales and a smaller loss suggests incremental progress in MicroVision’s efforts to scale its lidar and perception technology business. We'll examine how this early revenue growth and reduced quarterly loss could influence...